The DNA / RNA autophagy protein SIDT2 as a novel neuropathological hallmark in Huntington disease
Brain Pathology · 2026-09 · 36 (5)
DOI: 10.1111/bpa.70088 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Pathology, online erschienen am 24.02.2026. Verfasst von Sanaz Gabery und 17 weiteren Autor:innen. Beteiligte Einrichtung: Translational Neuroendocrine Research Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Huntington Disease, Autophagy, Brain, Membrane Proteins. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, Hjärnfonden, Foundation of King Gustav V and Queen Victoria.
Abstract (Originalsprache)
The pathogenic mechanisms leading to neurodegeneration in Huntington disease (HD) are not fully understood but involve accumulation of toxic mRNA and protein products in the brain. Recent studies described an unconventional autophagic pathway involving DNA and RNA degradation through DNautophagy and RNautophagy that is regulated by the lysosomal protein SID1 transmembrane family member 2 (SIDT2). Interestingly, SIDT2 has been shown to bind to the expanded CAG repeat in the mutant huntingtin (mHTT) transcript and lower mHTT in vitro. The aim of the present study was to determine whether SIDT2 levels are altered in HD and whether manipulation of SIDT2‐mediated RNautophagy can alter HD pathology. We demonstrate a significant reduction of SIDT2 protein levels in the striatum and in the lateral hypothalamic area in postmortem HD brains compared to control cases without effects on SIDT2 mRNA levels. In frontal cortical postmortem HD tissue, we show a CAG‐repeat‐length‐dependent increase in the frequency of SIDT2‐immunoreactive intranuclear inclusions. In postmortem tissue of an HD case with Vonsattel grade 0, we demonstrate SIDT2‐ and mHTT‐immunoreactive inclusions not only in the frontal cortex, but also in the striatum and the lateral hypothalamic area. In the R6/2 mouse model of HD, we show that SIDT2 inclusions form at later stages than mHTT inclusions. Overexpression of SIDT2 using adeno‐associated viral vectors injected into the hypothalamus of R6/2 mice led to a reduction of mHTT inclusions in the lateral hypothalamic area. Similarly, in a neuronal cell model, overexpression of SIDT2 reduced soluble and insoluble mHTT exon 1 protein levels. Taken together, our results reveal novel pathology in clinical HD cases and in experimental models, characterized by the accumulation of SIDT2‐immunoreactive inclusions, while demonstrating the efficacy of overexpressing SIDT2 for lowering detrimental mHTT species. Targeting SIDT2‐mediated RNautophagy may offer a potential strategy to ameliorate the molecular pathology in HD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Neuroendocrine Research Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden.
- Department of Human Genetics, Medical Faculty, Ruhr University Bochum, Bochum, Germany.
- Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
- Department of Neuroanatomy and Molecular Brain Research, Medical Faculty, Ruhr University Bochum, Bochum, Germany.
- Division of Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
- Department of Pathology, Alfred Hospital, Melbourne, Victoria, Australia.
ORCID-Profile: Sofia Bergh, Chrisovalantou Huridou, Paul Günther Scheunemann, Marie-Louisa Schoebel, Linda Holmquist Mengelbier, Elisabet Englund, Catriona McLean, Deniz Kirik, Glenda Halliday, Huu Phuc Nguyen, Jonasz Jeremiasz Weber, Åsa Petersén
Förderung
- Vetenskapsrådet
- Hjärnfonden
- Foundation of King Gustav V and Queen Victoria
- Region Skåne
- Knut och Alice Wallenbergs Stiftelse
- Deutsche Forschungsgemeinschaft
- National Health and Medical Research Council of Australia
- Deutsche Huntington Hilfe
Zitieren
APA
Gabery, S., Bergh, S., Huridou, C., Cheong, R. Y., Baldo, B., Scheunemann, P. G., Schoebel, M. L., Mengelbier, L. H., Englund, E., McLean, C., Saft, C., Kirik, D., Björkqvist, M., Halliday, G., Petrasch-Parwez, E., Nguyen, H. P., Weber, J. J., & Petersén, Å. (2026). The DNA / RNA autophagy protein SIDT2 as a novel neuropathological hallmark in Huntington disease. Brain Pathology, 36(5). https://doi.org/10.1111/bpa.70088
Vancouver
Gabery S, Bergh S, Huridou C, Cheong RY, Baldo B, Scheunemann PG, et al. The DNA / RNA autophagy protein SIDT2 as a novel neuropathological hallmark in Huntington disease. Brain Pathology. 2026;36(5). doi:10.1111/bpa.70088
BibTeX
@article{Gabery2026,
author = {Gabery, Sanaz and Bergh, Sofia and Huridou, Chrisovalantou and Cheong, Rachel Y and Baldo, Barbara and Scheunemann, Paul Günther and Schoebel, Marie-Louisa and Mengelbier, Linda Holmquist and Englund, Elisabet and McLean, Catriona and Saft, Carsten and Kirik, Deniz and Björkqvist, Maria and Halliday, Glenda and Petrasch-Parwez, Elisabeth and Nguyen, Huu Phuc and Weber, Jonasz Jeremiasz and Petersén, Åsa},
title = {The DNA / RNA autophagy protein SIDT2 as a novel neuropathological hallmark in Huntington disease},
journal = {Brain Pathology},
year = {2026},
volume = {36},
number = {5},
doi = {10.1111/bpa.70088}
}
EUVIMED